Emerging Novel Combined CAR-T Cell Therapies

Emerging Novel Combined CAR-T Cell Therapies

Chimeric antigen receptors (CAR) T cells are T cells engineered to express membrane receptors with high specificity to recognize specific target antigens presented by cancer cells and are co-stimulated with intracellular signals to increase the T cell response. CAR-T cell therapy is emerging as a no...

Full description

Bibliographic Details
Main Authors: Anh Nguyen, Gary Johanning, Yihui Shi
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
chimeric antigen receptor (CAR)
T cell
immunotherapy
hematologic malignancies
solid tumor
target antigen
Online Access:https://www.mdpi.com/2072-6694/14/6/1403

Similar Items

Similar Items